Company Filing History:
1 out of 1,155 
1 out of 509 
1 out of 896 
Years Active: 1992-2017
Title: The Innovative Contributions of Aaron Janowsky
Introduction
Aaron Janowsky is a notable inventor based in Portland, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the brain. With a total of two patents to his name, Janowsky's work has implications for both treatment and diagnostic applications in medicine.
Latest Patents
Janowsky's latest patents include innovative compounds that bind to the vesicular monoamine transporter 2 (VMAT2). These compounds are part of pharmaceutical compositions that offer methods of treatment for various conditions. Another significant patent involves radioiodinated benzamines, which serve as radioimaging agents in nuclear medicine. These novel, substituted benzamides are designed to detect, visualize, and analyze the distribution and function of the dopamine D-2 receptor in the mammalian brain. The synthesis of these compounds involves a unique reaction process that utilizes radioactive iodine.
Career Highlights
Throughout his career, Janowsky has worked with prestigious institutions such as Vanderbilt University and Oregon Health & Science University. His research has focused on the intersection of chemistry and medicine, leading to advancements in how certain brain functions can be monitored and treated.
Collaborations
Janowsky has collaborated with esteemed colleagues, including Tomas De Paulis and Robert M Kessler. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Aaron Janowsky's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and diagnostic techniques.